{"id":"mk0928-gaboxadol","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Somnolence"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1255746","moleculeType":"Small molecule","molecularWeight":"176.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gaboxadol selectively activates extrasynaptic GABA-A receptors containing the delta subunit, which are thought to mediate tonic inhibition in the brain. This mechanism differs from traditional benzodiazepines and may provide anxiolytic and sleep-promoting effects with potentially improved tolerability and reduced abuse potential.","oneSentence":"Gaboxadol is a selective GABA-A receptor agonist that enhances inhibitory neurotransmission in the central nervous system.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:42.900Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia"},{"name":"Anxiety disorders"}]},"trialDetails":[{"nctId":"NCT00095043","phase":"PHASE3","title":"Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2004-10","conditions":"Insomnia","enrollment":320},{"nctId":"NCT00094627","phase":"PHASE3","title":"Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2004-11","conditions":"Primary Insomnia","enrollment":465},{"nctId":"NCT00095069","phase":"PHASE3","title":"Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2004-10","conditions":"Insomnia","enrollment":600},{"nctId":"NCT00103818","phase":"PHASE3","title":"An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2005-02","conditions":"Insomnia","enrollment":900},{"nctId":"NCT00102167","phase":"PHASE3","title":"Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2005-02","conditions":"Insomnia","enrollment":663},{"nctId":"NCT00266357","phase":"PHASE2","title":"Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2005-11","conditions":"Primary Insomnia","enrollment":50},{"nctId":"NCT00102154","phase":"PHASE3","title":"An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)","status":"WITHDRAWN","sponsor":"H. Lundbeck A/S","startDate":"2005-01","conditions":"Insomnia","enrollment":""},{"nctId":"NCT00094666","phase":"PHASE3","title":"Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2004-11","conditions":"Primary Insomnia","enrollment":465},{"nctId":"NCT00266344","phase":"PHASE2","title":"MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2005-11","conditions":"Primary Insomnia","enrollment":520}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":224,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MK0928, gaboxadol","genericName":"MK0928, gaboxadol","companyName":"H. Lundbeck A/S","companyId":"h-lundbeck-a-s","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gaboxadol is a selective GABA-A receptor agonist that enhances inhibitory neurotransmission in the central nervous system. Used for Insomnia, Anxiety disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}